CG
LUMO

Cutler Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Cutler Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-156
Closed -$5K – 5042
2018
Q1 		$5K Sell
156
-1,444
-90% -$102K ﹤0.01% 3335
2017
Q4 		$17K Sell
1,600
-1,056
-40% -$87.3K ﹤0.01% 2718
2017
Q3 		$64K Buy
2,656
+734
+38% +$56.3K ﹤0.01% 2023
2017
Q2 		$96K Buy
1,922
+222
+13% +$27.5K ﹤0.01% 1894
2017
Q1 		$31K Sell
1,700
-1,078
-39% -$154K ﹤0.01% 2877
2016
Q4 		$132K Sell
2,778
-2,689
-49% -$303K ﹤0.01% 1653
2016
Q3 		$336K Sell
5,467
-366
-6% -$36.4K 0.02% 837
2016
Q2 		$545K Sell
5,833
-5,423
-48% -$672K 0.03% 544
2016
Q1 		$767K Buy
11,256
+1,678
+18% +$340K 0.05% 346
2015
Q4 		$488K Buy
+9,578
New +$3.12M 0.03% 619

Other funds holding LUMO

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's LUMO Position: Q4 2019 in Review

Cutler Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2019, closing a stake of 167 shares — an estimated $2K sold.

Cutler Group first reported a position in LUMO in Q4 2015 and held it in 16 quarters. The position peaked at $1.23M in Q4 2015. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

  • Cutler Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Cutler Group sold 167 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $2K.
  • Cutler Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Lumos Pharma, Inc. Common Stock position peaked at $1.23M in Q4 2015.
  • 64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.